Brief: Ryvu Therapeutics Signs Annex To Framework Deal With Icon Clinical Research Which Ups Total Deal Value To EUR 5.6 Mln
17/12/2021 16:57
Dec 17 (Reuters) - Ryvu Therapeutics SA RVU.WA :
* SIGNS ANNEX TO FRAMEWORK DEAL WITH ICON CLINICAL RESEARCH
WHICH
UPS TOTAL DEAL VALUE TO EUR 5.6 MILLION
Source text for Eikon: ID:nEM7RzrPMa
Further company coverage: RVU.WA
(Reporting by Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com;))
Recent news on Ryvu Therapeutics SA
See all newsBrief: Ryvu Therapeutics Signs Grant Agreement For Panacea-Novo Project With The National Center For Research And Development
Brief: Ryvu Therapeutics Q2 Net Loss 13.1 Million Zlotys
Brief: Ryvu Therapeutics "Dualis" Project Recommended For 22.2 Mln Zloty Subsidy
Brief: Ryvu Therapeutics Launches Early Clinical Development Services Business For Biotech And Pharma In Europe
Brief: Ryvu Therapeutics Says Panacea-Novo Project Recommended For Funding Of 106.7 Mln Zlotys